[1]
Kale, M.R., Baig, M.S. and Lamb, A. 2019. A prospective observational pharmacovigilance study of adverse drug reaction monitoring in patients of tuberculosis receiving category I and II treatment regimens at tertiary care hospital. International Journal of Basic & Clinical Pharmacology. 8, 5 (Apr. 2019), 875–880. DOI:https://doi.org/10.18203/2319-2003.ijbcp20191568.